Skip to main content
. Author manuscript; available in PMC: 2019 Apr 15.
Published in final edited form as: J Affect Disord. 2018 Feb 5;231:51–57. doi: 10.1016/j.jad.2018.01.027

Table 4.

Type III tests of fixed effects (n=41)


Drug F (p)a Minutes F (p)b Drug*Minutes F (p)b
Constructs




Depressed Mood 43.40 (<.0001) 3.30 (.004) 2.00 (.07)




Tension 41.22 (<.0001) 9.02 (<.0001) 3.31 (.004)




Negative Cognition 48.90 (<.0001) 9.8 (<.0001) 3.08 (.006)




Impaired Sleep 13.19 (.0009) 1.45 (.194) 0.30 (.94)




Suicidal Thoughts 47.96 (<.0001) 9.42 (<.0001) 4.32 (.0003)




Reduced Appetite 0.59 (.44) 2.78 (.01) 7.33 (<.0001)




Anhedonia 18.07 (.0001) 1.99 (.07) 0.71 (.64)




Amotivation 38.50 (<.0001) 3.83 (.001) 0.55 (.77)




Conventional Scores




BDI Total 44.19 (<.0001) 8.10 (<.0001) 1.38 (.22)




HAM-D Total 36.09 (<.0001) 4.68 (.0001) 1.22 (.30)




MADRS Total 47.37 (<.0001) 3.90 (.0009) 1.62 (.14)




SHAPS Total 15.41 (.0003) 2.32 (.03) 0.77 (.60)




a

Numerator DF was 1, denominator DF ranged from 31.3 to 57.2.

b

Numerator DF was 6, denominator DF ranged from 290 to 384.

Note: BDI: Beck Depression Inventory; HAM-D: Hamilton Rating Scale for Depression; MADRS: Montgomery-Asberg Depression Rating Scale; SHAPS: Snaith Hamilton Pleasure Scale; DF: degrees of freedom. Results of a mixed model with compound symmetry covariance structure for repeated measures, random subject effect, and Satterthwaite’s approximation for degrees of freedom. Period-specific baseline was entered as a covariate.